For Patients For Physicians Treatments and Procedures News Career Opportunities Online Appointment Request Download and Print Patient Forms Referring Physician Form
Text Resize

Jetrea (Ocriplasmin)

Jetrea is an FDA approved injectable medication that contains a proteolytic enzyme use to treat patient with symptomatic vitreomacular adhesion (VMA). VMA occurs when the vitreous cannot completely separate from the macula as part of the normal aging process. VMA can lead to symptomatic VMA if the adhesion is strong enough to cause pulling on the macula. This pulling is known as vitreomacular traction and can harm the macular structure and lead to loss in visual acuity.








Home Page Meet Our Physicians Our Services Make an Appointment